UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 861177
NEW YORK, NY
Position in ALNY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$219,104,078
-$5,066,628 QoQ
Shares Held
727,848
+7.4% QoQ
Ownership
0.544%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#35
of 780 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 51%
Shared 0%
None 49%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. ALNY ranks #3 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in ALNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $219,104,078 | 727,848 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $224,170,706 | 677,519 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $259,413,334 | 652,366 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $323,105,184 | 708,564 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $312,503,779 | 958,336 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $198,764,684 | 736,111 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $167,210,811 | 710,598 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $194,234,705 | 706,231 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $203,005,359 | 835,413 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $113,380,237 | 758,650 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $141,846,480 | 741,061 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $137,159,695 | 774,476 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $127,996,383 | 673,878 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $134,991,234 | 673,878 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $156,354,682 | 657,920 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $120,802,963 | 603,532 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $86,521,423 | 593,222 | Shares | Other | 2022-08-12 | |
| 2022-03-31 | $98,817,385 | 605,165 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $108,651,596 | 640,710 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $121,890,445 | 645,572 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $105,649,603 | 623,228 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $93,966,034 | 665,529 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $91,685,380 | 705,435 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $105,301,557 | 723,225 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $124,060,930 | 837,627 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $90,496,362 | 831,386 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||